Skip to content

NEUROPROTECTION FOR MAINTENANCE OF VISUAL FUNCTION IN PATIENTS

NEUROPROTECTION FOR MAINTENANCE OF VISUAL FUNCTION IN PATIENTS WITH ADVANCED PRIMARY GLAUCOMA - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097499
Enrollment
80
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Evaluation of the Effect of a Homotaurine-, Carnosine-, Forskolin-, Vitamin B , Folic Acid , and Magnesium-Based Supplement on Foveal Sensitivity and PERG Amplitude in Advanced Primary

Sponsors

Nethradhama Super Speciality Eye Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of advanced primary glaucoma Intraocular pressure is compensated by topical antiglaucoma medication

Exclusion criteria

Exclusion criteria: Patients with a diagnosis of secondary glaucoma Intolerance at 1 or more ingredients of the food supplement Patients who are pregnant or breastfeeding Patients who are involved in other trials simultaneously

Design outcomes

Primary

MeasureTime frame
To assess the effect of daily intake of homotaurine, carnosine, forskolin, vitamins B1, B2, B6, folic acid and magnesium based supplement along with topical antiglaucoma therapy on foveal sensitivity, pattern electroretinogram [PERG] amplitude in patients with advanced primary glaucoma compared with a control population only on topical therapy.Timepoint: 3month,6month,9month

Secondary

MeasureTime frame
2. To assess any further decrease of intraocular pressure in patients treated with food supplement along with topical antiglaucoma therapy compared with control patients only on topical therapy.Timepoint: 3month,6month,9month

Countries

India

Contacts

Public ContactDr KOMMINENI SINDUSHA

Nethradhama Super Speciality Eye Hospital

sindusha1995@gmail.com6304343013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026